New Antidiabetic Drugs 2023
Thẻ 1 Victoza & Saxenda Semaglutide Byetta and Bydureon Exenatide Victoza & Saxenda 1. Liraglutide is a medication used in the treatment of type 2 diabetes and obesity. 2. It is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that mimics the action of the hormone GLP-1. 3. Liraglutide is available as a subcutaneous injection. 4. Concentrations: Liraglutide is available in two concentrations: 6 mg/mL and 18 mg/mL. 5. Trade Names: Liraglutide is commonly marketed under the brand name Victoza (for diabetes) and Saxenda (for obesity). 6. Diabetes Dose: For diabetes management, the recommended starting dose of liraglutide is 0.6 mg once daily. It can be increased to 1.2 mg once daily or 1.8 mg once daily based on individual response and tolerability. 7. Obesity Dose: Saxenda is injected once per day, preferably at the same time every day. It is given as an injection under the skin in the thigh, upper arm or abdomen (belly). The starting dose is 0.6 mg per day. The dose is...